OtherNeuropharmacology
METHYLPHENIDATE-INDUCED INCREASES IN VESICULAR DOPAMINE SEQUESTRATION AND DOPAMINE RELEASE IN THE STRIATUM: THE ROLE OF MUSCARINIC AND DOPAMINE D2 RECEPTORS
Trent Volz, Sarah Farnsworth, Shane D. Rowley, Glen R. Hanson and Annette E. Fleckenstein
Journal of Pharmacology and Experimental Therapeutics June 30, 2008, DOI: https://doi.org/10.1124/jpet.108.139386
Trent Volz
Sarah Farnsworth
Shane D. Rowley
Glen R. Hanson
Annette E. Fleckenstein
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherNeuropharmacology
METHYLPHENIDATE-INDUCED INCREASES IN VESICULAR DOPAMINE SEQUESTRATION AND DOPAMINE RELEASE IN THE STRIATUM: THE ROLE OF MUSCARINIC AND DOPAMINE D2 RECEPTORS
Trent Volz, Sarah Farnsworth, Shane D. Rowley, Glen R. Hanson and Annette E. Fleckenstein
Journal of Pharmacology and Experimental Therapeutics June 30, 2008, DOI: https://doi.org/10.1124/jpet.108.139386
OtherNeuropharmacology
METHYLPHENIDATE-INDUCED INCREASES IN VESICULAR DOPAMINE SEQUESTRATION AND DOPAMINE RELEASE IN THE STRIATUM: THE ROLE OF MUSCARINIC AND DOPAMINE D2 RECEPTORS
Trent Volz, Sarah Farnsworth, Shane D. Rowley, Glen R. Hanson and Annette E. Fleckenstein
Journal of Pharmacology and Experimental Therapeutics June 30, 2008, DOI: https://doi.org/10.1124/jpet.108.139386
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement